Helping to improve your quality of life.
Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases through an innovative discovery and development platform.
Pharmaceutical Product Pipeline
Ampio has advanced its lead development assets into late-stage, pivotal clinical trials in the US.
Learn More About:
Ampio is developing Ampion™ for the treatment of osteoarthritis of the knee.
Ampio is developing Optina™ for the treatment of Diabetic Macular Edema.
|AMPE Stock Quote - delayed|
04/22/2014 | Press Release
04/21/2014 | Press Release
04/10/2014 | Press Release